ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 984,93
-0,99%
Dow Jones
37 903,29
0,23%
DAX
17 932,17
-1,10%
Brent Oil
83,725
0,22%
Bitcoin
57 278,77
-1,65%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Titan Pharmaceuticals Inc (TTNP)

  7. Titan Pharmaceuticals Inc (TTNP) Actualités

TTNP Titan Pharmaceuticals Inc

6,70
-0,005 (-0,07%)
01 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Titan Pharmaceuticals Inc TTNP NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-0,005 -0,07% 6,70 23:16:11
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
6,60 6,60 7,04 6,70 6,705
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
25/1/202422:33EDGAR2Form 8-K - Current report
25/1/202422:29GLOBETitan Pharmaceuticals Fully Compliant With NASDAQ Listing..
18/1/202422:59EDGAR2Form 8-K - Current report
08/1/202423:13EDGAR2Form 8-K - Current report
28/12/202322:30EDGAR2Form 8-K - Current report
28/12/202322:15GLOBETitan Pharmaceuticals Announces Reverse Stock Split and..
28/11/202322:47EDGAR2Form DEF 14A - Other definitive proxy statements
17/11/202322:03EDGAR2Form PRE 14A - Other preliminary proxy statements
15/11/202322:05EDGAR2Form 8-K - Current report
26/10/202322:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/10/202322:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/10/202322:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/10/202322:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/10/202322:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/10/202323:26EDGAR2Form S-8 - Securities to be offered to employees in employee..
23/10/202321:07EDGAR2Form 3 - Initial statement of beneficial ownership of..
16/10/202323:08EDGAR2Form 8-K - Current report
16/10/202322:37GLOBETitan Pharmaceuticals Announces Appointment of Dato' Seow..
04/10/202323:30EDGAR2Form SC 13D - General statement of acquisition of beneficial..
19/9/202322:41EDGAR2Form 8-K/A - Current report: [Amend]
18/9/202322:45EDGAR2Form 8-K - Current report
18/9/202313:30GLOBETitan Pharmaceuticals Announces $9.5 Million Private..
08/9/202323:30EDGAR2Form 8-K - Current report
30/8/202322:28EDGAR2Form 8-K - Current report
14/8/202323:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/8/202302:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/8/202301:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/8/202301:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/7/202323:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/7/202323:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/7/202323:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/7/202323:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/7/202313:30GLOBETitan Pharmaceuticals Announces Sale of Certain ProNeura..
21/7/202303:57EDGAR2Form SC 13D - General statement of acquisition of beneficial..
07/7/202316:28EDGAR2Form 8-K - Current report
29/6/202322:15EDGAR2Form 8-K - Current report

Dernières Valeurs Consultées

NASDAQ
TTNP
Titan Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés